SPAC Presentation

Procaps at a Glance Regional Leader with Strong Diversification by Product and Geography Key Highlights ■ ■ -44% of Procaps' revenue is USD-denominated. Leader in both Colombia and Central America, which combined represents one of the largest pharma markets in LatAm¹ Well positioned in key markets with attractive growth prospects Gross Revenue by Product Line (2020) Diabetes Solutions OTC Products Rx Drugs CLINICAL -16%. VitalCare 16% 17% -6%- DIABETRICS 361" EN FUNCIÓN DE LA VIDA -49%* 6% US$388mm 32% Softi 29% FARMA PROCAPS -29% % Sales CDMO Gross Revenue by Geography (2020) CenAm S. 4% Peru 4% Brazil 7% Bolivia 3% CenAm N. 14% USA & Other 18% US$388mm Source: Procaps, Fitch Solutions Note: (1) Colombia and Central America on a combined basis have approximately the same amount of pharma sales as Mexico. Fitch Solutions market reports as of 2020 PROCAPS Ecuador 3% GROUP % Sales by country of commercialization Colombia 47% * 11

View entire presentation